“…5 Although CVC is not the gold standard, mainly due to infections and thrombotic complications, its permanent insertion is still a reality in patients in which the fistula may present difficulty in maturation, such as in cases of diabetes, hypertension, coagulopathies, neurological and immunological pathologies, or due to thromboembolic adverse events in AVF. 6 Regarding the use of AVF, one of the main problems is the high frequency of primary failures, due to lack of maturation or early thrombosis, in addition, other complications may also arise, such as aneurysms, infections and venous hypertension. 7 The development of thrombi is common to both CVC and AVF and activates both the blood clotting process and the expression of platelet markers on platelet surfaces.…”